[Neoadjuvant chemotherapy: meta-analysis and interpretation of results in bladder cancer].
Pollera
Camillo F
CF
UOC di Oncologia, Presidio Ospedaliero Centrale, Belcolle, ASL di Viterbo.
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use*; D002295:Carcinoma, Transitional Cell / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D017024:Chemotherapy, Adjuvant; D003131:Combined Modality Therapy; D015653:Cystectomy; D018572:Disease-Free Survival; D006801:Humans; D015993:Life Tables; D015201:Meta-Analysis as Topic; D020360:Neoadjuvant Therapy; D009361:Neoplasm Invasiveness; D016032:Randomized Controlled Trials as Topic; D016019:Survival Analysis; D016896:Treatment Outcome; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D014547:Urinary Diversion